Hemera Pharma Receives Women Startup Award for Excellence in Regenerative Medicine

We are delighted to share Hemera Pharma’s recent achievements in the field of regenerative medicine.

On September 29, amidst the prestigious setting of OGR Torino, Hemera Pharma took the spotlight during the Italian Tech Week. Our CEO, Cristiana Vignoli, was honored with the Women Startup Award, powered by Intesa Sanpaolo Innovation Center, in recognition of the remarkable progress made in the field of regenerative medicine.

The award was granted to Hemera Pharma for its pioneering efforts in pursuing the ambitious goal of developing the world’s first therapy for spinal cord injury treatment. This milestone represents a tangible and vital response to an unmet global medical need.

This innovation promises to be a significant ethical and social breakthrough for society as a whole.